Karius Funding & Investors
Karius, Inc. operates as a life science company. The Company provides diagnostic tests and clinical data facilities. Karius also transforms infectious disease diagnostics by providing a validated test that can detect bacteria, DNA viruses, and eukaryotic pathogens including yeasts, molds, and protozoa. Karius serves markets in the United States.
kariusdx.comTotal Amount Raised: $354,000,000
Karius Funding Rounds
Series B
$165,000,000
Series B Investors
SoftBank Vision FundGeneral CatalystLightspeed Venture PartnersKhosla VenturesHBM Healthcare InvestmentsDebt Financing
$25,000,000
Debt Financing Investors
Oxford FinanceSeries A
$59,000,000
Series A Investors
Data Collective (DCVC)Lightspeed Venture PartnersKhosla VenturesTencentInnovation EndeavorsS28 CapitalPacific 8 VenturesaMoon FundSeries C
$100,000,000
Series C Investors
5am VenturesGilde HealthcareKhosla VenturesInnovation EndeavorsWaycross VenturesSoftBank Vision FundHBM Healthcare InvestmentsGeneral CatalystBlue Water Life Science FundSeventure PartnersSeed
$5,000,000
Seed Investors
Data Collective (DCVC)Lightspeed Venture PartnersInnovation Endeavors
Funding info provided by Diffbot.